An Open-Label, Multi-Center, Extension Study of Cyclosporine Inhalation Solution in Subjects Previously Enrolled in the APT Study CIS001. Submission of protocol dated 7/9/09, clarification memo dated 7/15/09, diary cards, script for the DVD for patient teaching, appointment cards reminders, instructions for removing and replacing the hose-barb connector on the invacare mobilarie compressor, and advertising brochure.
To provide access to CIS treatment to subjects previously enrolled in the APT study CIS001 or to subjects screened for CIS001 but not enrolled due to an SAE persisting beyond post-transplant day 70;To assess the long-term safety of CIS administration;To collect data on extended follow up and survival in lung transplant patients treated with CIS;To assess the long-term safety of CIS administration via the recording of serious adverse events and local respiratory adverse events associated with study drug administration during the titration phase.
202054081909
200